A key deliverable of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies is the Glossary. It is a glossary of pharmaceutical terms in English and comprises more than 350 terms, including several terms of relevance for the in-patient pharmaceutical sector. The glossary was developed as part of our work on the development and promotion of a common understanding and language on pharmaceutical issues (for further background information consult the section Methodology).
The Glossary is being regularly extended, revised and uploaded. The WHO Collaborating Centre is working on promoting a common understanding via the translation of the Glossary into national languages.
Online Glossary
The most updated version is available via the online search function.
Suggestion for citation of the online glossary:
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies (2025): Glossary of pharmaceutical terms. Vienna: Gesundheit Österreich (GÖG / Austrian National Public Health Institute). Available from: ppri.goeg.at/ppri-glossary
The PPRI glossary plus local translations for download can be found below.
English version of the Glossary (last update: August 2025)
The PPRI Glossary in pdf-format (version: August 2025) is available here for download.
Suggestion for citation:
Knoll, Verena; Vogler, Sabine (2025): PPRI Glossary of Pharmaceutical Terms. Update 2025. Gesundheit Österreich (GÖG / Austrian National Public Health Institute), Vienna. https://ppri.goeg.at/ppri-glossary/
Previous versions:
- The pdf version of the 2019 update of the Glossary is available here for download.
- The pdf version of the 2016 update of the Glossary is available here for download.
Translations
German (last update: 2017)
Pharma_Glossar_deutsch_Update2017.pdf
Russian (last update: 2021)
Glossary_FINAL_RU.pdf (2017)
Spanish (last update: 2012)
Spanish%20Glossary%20final.pdf
Thematic glossaries:
Glossary on Medical Devices (2022)
Working definitions of terms related to biosimilars policies for the study on “Capacity building to support the uptake of biosimilars in a multistakeholder approach” (Version: June 2025)